SOPHiA GENETICS to Present at the 40th Annual J.P. Morgan Healthcare Conference
December 29 2021 - 7:00AM
SOPHiA GENETICS SA (Nasdaq: SOPH), announced today Chief Executive
Officer and Co-Founder Dr. Jurgi Camblong and Chief Financial
Officer Ross Muken, will participate in the upcoming 40th Annual
J.P. Morgan Healthcare Conference. The virtual presentation will
begin at 8:15 a.m. ET/2:15 p.m. CET on Tuesday, January 11, 2022
and will be available live and archived on SOPHiAGENETICS.COM, in
the Investor Relations section.
About SOPHiA GENETICS
SOPHiA GENETICS (Nasdaq: SOPH) is a healthcare technology
company dedicated to establishing the practice of data-driven
medicine as the standard of care and for life sciences research. It
is the creator of the SOPHiA DDM™ Platform, a cloud-based SaaS
platform capable of analyzing data and generating insights from
complex multimodal data sets and different diagnostic modalities.
The SOPHiA DDM™ Platform and related solutions, products and
services are currently used by more than 780 hospital, laboratory,
and biopharma institutions globally. For more information, visit
SOPHiAGENETICS.COM, or connect on Twitter, LinkedIn and Instagram.
Where others see data, we see answers.
Investor Contact:Jennifer PottageHead of
Investor RelationsJpottage@sophiagenetics.com
Media Contact:Eliza BamontiDirector of Public
RelationsEbamonti@sophiagenetics.com
Sophia Genetics (NASDAQ:SOPH)
Historical Stock Chart
From May 2024 to Jun 2024
Sophia Genetics (NASDAQ:SOPH)
Historical Stock Chart
From Jun 2023 to Jun 2024